2 Patents
- US124484542025Humanized Anti-clec-1a Antibodies and Antigen-binding Fragments Thereof
OSE IMMUNOTHERAPEUTICS
0 cites - US120914642024Method of Promoting a T-cell Response or Treating Cancer by Administering an Antagonist to Human C-type Lectin-like Receptor-1 (CLEC-1)
OSE IMMUNOTHERAPEUTICS
0 cites